The question bank is the fastest way to start, but PMHNP Helper also includes board-review planning, student resources, and plain-English guidance for psychiatric nurse practitioner students who are still learning the exam landscape.
A 41-year-old woman presents with a 6-month history of persistent worry, restlessness, muscle tension, depressed mood, and loss of interest in activities. She meets DSM-5 criteria for both generalized anxiety disorder and major depressive disorder. She has no history of seizures, substance use, or cardiac disease. She is seeking pharmacotherapy that can address both conditions.
Explanation
When anxiety and depression coexist, the optimal approach is a single agent that addresses both conditions. SSRIs and SNRIs with dual FDA indications are the appropriate choices. Bupropion is a common source of error in this context, as it treats depression but can worsen anxiety.
Key Takeaway
For comorbid GAD and MDD, choose an SSRI or SNRI with FDA approval for both conditions to maximize efficacy with a single agent.